University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Atripla

Sustiva + Viread + Emtriva (Atripla)

Type of Drug: Fixed-Dose Combination
Fixed-dose combinations combine the most commonly prescribed doses of 2 or more medications into a single pill.

Approved adult dosing

Sustiva 600 mg + Viread 300 mg + Emtriva 200 mg in a single tablet

one tablet, at bedtime

  • Once daily



Notes on taking this medication

  • Take at bedtime
  • Take on an empty stomach
  • The Sustiva component interacts with many other drugs; consult your medical provider
  • Persons with kidney problems may need an adjustment to their doses of the component drugs, so may not be able to take this combination pill

Same possible side effects as


  • Sleep disturbances such as vivid dreams (improves over the first several weeks); dizziness; drowsiness; mood disturbances, suicidality
  • Difficulty with concentration
  • Rash
  • Do not take during first trimester of pregnancy or if you may become pregnant while taking it; may cause birth defects


  • Gassiness; abdominal discomfort; nausea; diarrhea
  • Kidney impairment
  • Bone impairment
  • Viread is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B


  • Skin discoloration (particularly in dark-skinned people)
  • Emtriva is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

Scroll over drug name to see other names for the drug.